Superiority of Glimepiride Over Sitagliptin in Naive Type 2 Diabetes Patients

NCT00957060 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

400

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: GLIMEPIRIDE (HOE490)
DRUG: SITAGLIPTIN

Sponsor

Sanofi